Prosperity Consulting Group LLC Has $275,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Prosperity Consulting Group LLC increased its holdings in CME Group Inc. (NASDAQ:CME) by 27.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,401 shares of the financial services provider’s stock after acquiring an additional 300 shares during the period. Prosperity Consulting Group LLC’s holdings in CME Group were worth $275,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. B. Riley Wealth Advisors Inc. boosted its position in shares of CME Group by 1.3% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after acquiring an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC raised its stake in CME Group by 4.3% in the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares in the last quarter. Lantz Financial LLC lifted its position in CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after purchasing an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its stake in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares in the last quarter. Finally, Greystone Financial Group LLC increased its holdings in shares of CME Group by 1.6% in the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after buying an additional 52 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ:CME opened at $216.99 on Monday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The firm has a market cap of $78.13 billion, a PE ratio of 24.69, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The business has a 50 day moving average price of $205.69 and a 200-day moving average price of $207.50.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue was up 12.7% compared to the same quarter last year. During the same period in the prior year, the business posted $2.30 EPS. Equities research analysts predict that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. The ex-dividend date is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.12%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have recently issued reports on CME. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Barclays lifted their price target on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Bank of America lowered CME Group from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft boosted their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Finally, JPMorgan Chase & Co. increased their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $209.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.